Post-approval studies (Phase 4)Study completedNCT07739589
What this trial is testing
A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal System
Who this might be right for
Residual Drug Amount of EE and LNG
Insud Pharma 28